NEW YORK (GenomeWeb) — Quadrant Biosciences said today that it has received a $2 million grant from the National Institutes of Health to finalize development of a saliva-based diagnostic for autism spectrum disorder (ASD).
NEW YORK (GenomeWeb) — Quadrant Biosciences said today that it has received a $2 million grant from the National Institutes of Health to finalize development of a saliva-based diagnostic for autism spectrum disorder (ASD).
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.